Positive rates of Mycoplasma pneumoniae antibodies in children before, during and after COVID-19 outbreak: an observational study in Chengdu, China from 2017 to 2024
Following the COVID-19 pandemic, a substantial increase of <i>Mycoplasma pneumoniae</i> (<i>M. pneumoniae</i>) antibody positive rates was observed among pediatric populations in Chengdu beginning in 2023. This study presents a descriptive analysis of serum antibody detection results, offering baseline epidemiological data to inform prevention and control strategies for <i>M. pneumoniae</i> infections among children in the Chengdu region.
Authors
- Liming Yan (ORCID: https://orcid.org/0000-0003-0648-9604)
- Meimei Lai
- Lei Zhang (ORCID: https://orcid.org/0000-0001-7769-7377)
- Hao Dong
- Haiyan Zhang (ORCID: https://orcid.org/0000-0002-3270-8965)
- Z. Z. Du (ORCID: https://orcid.org/0009-0003-4567-982X)
Institutions
- University of Electronic Science and Technology of China (CN)
- Affiliated Hospital of Southwest Medical University (CN)
- Chengdu Women's and Children's Central Hospital (CN)
Publication Details
- Journal
- Frontiers in Microbiology
- Published
- 2025-09-16
- DOI
- https://doi.org/10.3389/fmicb.2025.1649615
- Citations
- 1
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- University of Electronic Science and Technology of China